Journal of the Chemical Society. Perkin transactions I p. 3017 - 3026 (1991)
Update date:2022-08-05
Topics:
Carroll, F. Ivy
Abraham, Philip
Gaetano, Kevan
Mascarella, S. Wayne
Wohl, Ronald A.
et al.
(3S)-3-Hydroxyquinidine, the major metabolite of the Cinchona alkaloid quinidine, was prepared by synthetic chemical modification or microbial oxidation of quinidine.The structure of this metabolite has been demonstrated to be (3S)-3-hydroxyquinidine by 1H and 13C NMR, IR, UV and mass spectral analysis.Previously published comparisons of the 13C NMR spectra of 3-hydroxyquinidine and model compounds were used to establish the absolute stereochemistry of the metabolite (see ref. 8).This assignment has been verified by single-crystal X-ray analysis of (3S)-3-hydroxyquinidine methanesulphonate.The gas- and solution-phase conformational preference of the metabolite derived from molecular modelling and NOE studies are compared with the conformation observed by X-ray crystallography.
View MoreShanghai Yuantai Chemical Products Co., Ltd
Contact:021--66129803
Address:Chengyin Road,Shanghai,China
Global United Biotechnology Inc.
Contact:+86-21-61618568
Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Kaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
Contact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Doi:10.1016/j.poly.2012.05.031
(2012)Doi:10.1055/s-0035-1560198
(2016)Doi:10.1007/s10593-012-1039-6
(2012)Doi:10.1002/anie.201201288
(2012)Doi:10.1016/j.tet.2014.06.061
(2014)Doi:10.1039/c5ra21963a
(2015)
